British Journal of Cancer - Table of Contents alert Volume 112 Issue 9

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 112, Issue 9 (1421-1615) Published online 28 April 2015 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Letters to the Editor Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Minireview Top Anti-programmed cell death protein-1/ligand-1 therapy in different cancers B Homet Moreno and A Ribas Br J Cancer 2015 112: 1421-1427; advance online publication, April 9, 2015; 10.1038/bjc.2015.124 Abstract | Full Text Clinical Studies Top Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer S Ohkawa, T Okusaka, H Isayama, A Fukutomi, K Yamaguchi, M Ikeda, A Funakoshi, M Nagase, Y Hamamoto, S Nakamori, Y Tsuchiya, H Baba, H Ishii, Y Omuro, M Sho, S Matsumoto, N Yamada, H Yanagimoto, M Unno, Y Ichikawa, S Takahashi, G Watanabe, G Wakabayashi, N Egawa, M Tsuda, R Hosotani, C Hamada and I Hyodo Br J Cancer 2015 112: 1428-1434; advance online publication, April 16, 2015; 10.1038/bjc.2015.103 Abstract | Full Text The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people T Kalsi, G Babic-Illman, P J Ross, N R Maisey, S Hughes, P Fields, F C Martin, Y Wang and D Harari Br J Cancer 2015 112: 1435-1444; advance online publication, April 14, 2015; 10.1038/bjc.2015.120 Abstract | Full Text Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? D J A Lobbezoo, R J W van Kampen, A C Voogd, M W Dercksen, F van den Berkmortel, T J Smilde, A J van de Wouw, F P J Peters, J M G H van Riel, N A J B Peters, M de Boer, P G M Peer and V C G Tjan-Heijnen Br J Cancer 2015 112: 1445-1451; advance online publication, April 16, 2015; 10.1038/bjc.2015.127 Abstract | Full Text Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients O A Catalano, E Nicolai, B R Rosen, A Luongo, M Catalano, C Iannace, A Guimaraes, M G Vangel, U Mahmood, A Soricelli and M Salvatore Br J Cancer 2015 112: 1452-1460; advance online publication, April 14, 2015; 10.1038/bjc.2015.112 Abstract | Full Text Translational Therapeutics Top Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage A Reeder, M Attar, L Nazario, C Bathula, A Zhang, D Hochbaum, E Roy, K L Cooper, S Oesterreich, N E Davidson, C A Neumann and M S Flint Br J Cancer 2015 112: 1461-1470; advance online publication, April 16, 2015; 10.1038/bjc.2015.133 Abstract | Full Text Diffusion-weighted MRI for imaging cell death after cytotoxic or apoptosis-inducing therapy E Papaevangelou, G S Almeida, Y Jamin, S P Robinson and N M deSouza Br J Cancer 2015 112: 1471-1479; advance online publication, April 16, 2015; 10.1038/bjc.2015.134 Abstract | Full Text MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms E B Amankwatia, P Chakravarty, F A Carey, S Weidlich, R J C Steele, A J Munro, C R Wolf and G Smith Br J Cancer 2015 112: 1480-1490; 10.1038/bjc.2015.125 Abstract | Full Text Molecular Diagnostics Top C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer D Sun, C Wang, S Long, Y Ma, Y Guo, Z Huang, X Chen, C Zhang, J Chen and J Zhang Br J Cancer 2015 112: 1491-1500; advance online publication, March 31, 2015; 10.1038/bjc.2015.107 Abstract | Full Text IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer K Abiko, N Matsumura, J Hamanishi, N Horikawa, R Murakami, K Yamaguchi, Y Yoshioka, T Baba, I Konishi and M Mandai Br J Cancer 2015 112: 1501-1509; advance online publication, March 31, 2015; 10.1038/bjc.2015.101 Abstract | Full Text Efficient and reproducible generation of tumour-infiltrating lymphocytes for renal cell carcinoma V Baldan, R Griffiths, R E Hawkins and D E Gilham Br J Cancer 2015 112: 1510-1518; advance online publication, March 17, 2015; 10.1038/bjc.2015.96 Abstract | Full Text Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer H Ueo, K Sugimachi, T M Gorges, K Bartkowiak, T Yokobori, V Müller, Y Shinden, M Ueda, H Ueo, M Mori, H Kuwano, Y Maehara, S Ohno, K Pantel and K Mimori Br J Cancer 2015 112: 1519-1526; advance online publication, April 16, 2015; 10.1038/bjc.2015.132 Abstract | Full Text The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients K Mavridis, F Gueugnon, A Petit-Courty, Y Courty, A Barascu, S Guyetant and A Scorilas Br J Cancer 2015 112: 1527-1535; advance online publication, March 31, 2015; 10.1038/bjc.2015.119 Abstract | Full Text Low-temperature plasma treatment induces DNA damage leading to necrotic cell death in primary prostate epithelial cells A M Hirst, M S Simms, V M Mann, N J Maitland, D O'Connell and F M Frame Br J Cancer 2015 112: 1536-1545; advance online publication, April 2, 2015; 10.1038/bjc.2015.113 Abstract | Full Text Epidemiology Top Age-specific risk of breast cancer in women with neurofibromatosis type 1 O O Seminog and M J Goldacre Br J Cancer 2015 112: 1546-1548; advance online publication, March 5, 2015; 10.1038/bjc.2015.78 Abstract | Full Text Who are the cancer survivors? A nationwide study in Denmark, 1943–2010 H B Hovaldt, N P Suppli, M H Olsen, M Steding-Jessen, D G Hansen, H Møller, C Johansen and S O Dalton Br J Cancer 2015 112: 1549-1553; advance online publication, February 26, 2015; 10.1038/bjc.2015.68 Abstract | Full Text The significant survival advantage of female sex in nasopharyngeal carcinoma: a propensity-matched analysis P-Y OuYang, L-N Zhang, X-W Lan, C Xie, W-W Zhang, Q-X Wang, Z Su, J Tang and F-Y Xie Br J Cancer 2015 112: 1554-1561; advance online publication, March 5, 2015; 10.1038/bjc.2015.70 Abstract | Full Text Nationwide bowel cancer screening programme in England: cohort study of lifestyle factors affecting participation and outcomes in women R G Blanks, V S Benson, R Alison, A Brown, G K Reeves, V Beral, J Patnick and J Green Br J Cancer 2015 112: 1562-1567; advance online publication, March 5, 2015; 10.1038/bjc.2015.69 Abstract | Full Text Lifestyle and reproductive risk factors associated with anal cancer in women aged over 50 years K Coffey, V Beral, J Green, G Reeves and I Barnes on behalf of the Million Women Study Collaborators Br J Cancer 2015 112: 1568-1574; advance online publication, March 12, 2015; 10.1038/bjc.2015.89 Abstract | Full Text Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network A Smith, S Crouch, S Lax, J Li, D Painter, D Howell, R Patmore, A Jack and E Roman Br J Cancer 2015 112: 1575-1584; advance online publication, March 24, 2015; 10.1038/bjc.2015.94 Abstract | Full Text Human papillomavirus DNA in men who have sex with men: type-specific prevalence, risk factors and implications for vaccination strategies E M King, R Gilson, S Beddows, K Soldan, K Panwar, C Young, P Prah, M Jit, W J Edmunds and P Sonnenberg Br J Cancer 2015 112: 1585-1593; advance online publication, March 19, 2015; 10.1038/bjc.2015.90 Abstract | Full Text Using routinely collected data to stratify prostate cancer patients into phases of care in the United Kingdom: implications for resource allocation and the cancer survivorship programme K Yip, H McConnell, R Alonzi and J Maher Br J Cancer 2015 112: 1594-1602; advance online publication, March 19, 2015; 10.1038/bjc.2014.650 Abstract | Full Text Benzene exposure and risk of lymphohaematopoietic cancers in 25 000 offshore oil industry workers J S Stenehjem, K Kjærheim, M Bråtveit, S O Samuelsen, F Barone-Adesi, N Rothman, Q Lan and T K Grimsrud Br J Cancer 2015 112: 1603-1612; advance online publication, March 24, 2015; 10.1038/bjc.2015.108 Abstract | Full Text Letters to the Editor Top Inflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research D Rea, A Francis, A M Hanby, V Speirs, E Rakha, A Shaaban, S Chan, S Vinnicombe, I O Ellis, S G Martin, L J Jones and F Berditchevski on behalf of the UK Inflammatory Breast Cancer Working group Br J Cancer 2015 112: 1613-1615; advance online publication, March 31, 2015; 10.1038/bjc.2015.115 Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.